[fcb5af]: / literature / by_gene / NFKBIE.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35885481 10.3390/diagnostics12071575 2022 Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. NFKBIE
2 35964234 10.1093/ajcp/aqac087 2022 Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma. NFKBIE
3 32079702 10.3324/haematol.2019.237719 2021 Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. NFKBIE
4 32961552 10.1182/blood.2020007507 2021 Mutational landscape of gray zone lymphoma. NFKBIE
5 34405005 10.7150/jca.60390 2021 Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. NFKBIE
6 32012328 10.1002/hon.2718 2020 High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. NFKBIE
7 32170099 10.1038/s41408-020-0305-6 2020 Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice. NFKBIE
8 32585984 10.3390/cancers12061669 2020 Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma. NFKBIE
9 32947237 10.1016/j.tranon.2020.100855 2020 Identification of clinical molecular targets for childhood Burkitt lymphoma. NFKBIE
10 29449436 10.3324/haematol.2017.182048 2018 Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients. NFKBIE
11 29857068 10.1016/j.jid.2018.04.038 2018 Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. NFKBIE
12 29899297 10.3390/ijms19061758 2018 Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. NFKBIE
13 26647218 10.1158/1078-0432.CCR-15-2123 2016 Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. NFKBIE
14 27489104 10.1074/jbc.M116.719302 2016 The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs. NFKBIE
15 27670424 10.1182/blood-2016-03-704528 2016 Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. NFKBIE
16 25987724 10.1084/jem.20142009 2015 Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia. NFKBIE
17 19573080 10.1111/j.1365-2141.2009.07790.x 2009 Common genetic variants in candidate genes and risk of familial lymphoid malignancies. NFKBIE
18 19773279 10.1136/oem.2008.044024 2009 Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. NFKBIE
19 16360644 10.1016/j.bcp.2005.11.013 2006 Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity. NFKBIE
20 16464740 2005 Differential effects of tumor necrosis factor-alpha and CD40L on NF-kappa B inhibitory proteins I kappa B alpha, beta and epsilon and on the induction of the Jun amino-terminal kinase pathway in Ramos Burkitt lymphoma cells. NFKBIE
21 14595753 10.1002/path.1454 2003 Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. NFKBIE
22 10384125 1999 Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation. NFKBIE
23 9223487 10.1128/JVI.71.8.5972-5981.1997 1997 VBP and RelA regulate avian leukosis virus long terminal repeat-enhanced transcription in B cells. NFKBIE